| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.
|
JAMA
|
2001
|
24.12
|
|
2
|
Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence.
|
Circulation
|
2006
|
11.78
|
|
3
|
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.
|
J Am Coll Cardiol
|
2014
|
9.96
|
|
4
|
Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial.
|
JAMA
|
2010
|
8.53
|
|
5
|
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society.
|
Heart Rhythm
|
2012
|
8.03
|
|
6
|
Approaches to catheter ablation for persistent atrial fibrillation.
|
N Engl J Med
|
2015
|
6.68
|
|
7
|
Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial.
|
JAMA
|
2005
|
4.60
|
|
8
|
Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study.
|
Circulation
|
2008
|
4.43
|
|
9
|
Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial.
|
JAMA
|
2014
|
3.86
|
|
10
|
Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses.
|
Circ Arrhythm Electrophysiol
|
2009
|
3.09
|
|
11
|
Adenosine-guided pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation: an international, multicentre, randomised superiority trial.
|
Lancet
|
2015
|
2.50
|
|
12
|
Cost-effectiveness of cardioversion and antiarrhythmic therapy in nonvalvular atrial fibrillation.
|
Ann Intern Med
|
1999
|
2.15
|
|
13
|
Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study).
|
Eur Heart J
|
2013
|
1.83
|
|
14
|
Rising rates of hospital admissions for atrial fibrillation.
|
Epidemiology
|
2003
|
1.62
|
|
15
|
Ablation versus drugs: what is the best first-line therapy for paroxysmal atrial fibrillation? Antiarrhythmic drugs are outmoded and catheter ablation should be the first-line option for all patients with paroxysmal atrial fibrillation: pro.
|
Circ Arrhythm Electrophysiol
|
2014
|
1.49
|
|
16
|
How to ablate long-standing persistent atrial fibrillation?
|
Curr Opin Cardiol
|
2013
|
0.94
|